A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization’s Role as a Treatment Modality
Stanley T. Lewis
Frank Greenway
Tori R. Tucker
Michael Alexander
Levonika K. Jackson
Scott A. Hepford
Brian Loveridge
Jonathan R. T. Lakey
Physiologic hormone administration improves HbA1C in Native Americans with type 2 diabetes: A retrospective study and review of insulin secretion and action
Candida J. Rebello
Tyler S. Morales
Katsya Chuon
Shu Dong
V. Tyrone Lam
Dan Purner
Stanley Lewis
Jonathan Lakey
Robbie A. Beyl
Frank L. Greenway
Improved HOMA-IR Insulin Sensitivity and Glycemic Control Utilizing Physiologic Insulin Resensitization
Brian Loveridge
Michael Alexander
Zach Villaverde
Natalie Parkin
Shelley Messerly
Jonathan RT Lakey
Reversal of diabetic retinopathy in two patients following the use of physiologic insulin Resensitization
Randal T. Pham
Aarin Pham-Hoang
Stanley T. Lewis
Frank Greenway
Amr Dessouki
Richard M. Grimes
Insulin Infusion Therapy on Diabetic Complications, Medications, Quality of Life, Hemoglobin A1C, and Metabolic Functioning: Retrospective Analyses
Kim Dunn, MD, Ph.D.
David Hayes, Pharm.D.
Sandra Petersen, DNP
William J. Schull, Ph.D.
Effects of Physiologic Insulin Resensitization Therapy in Patients with Diabetes
Emily Hartley and Alina Maleski Smith, MHA
Department of Internal Medicine
Mercer University School of Medicine | Savannah campus
Improved Kidney Function Following Physiologic Insulin Resensitization Treatment Modality
Zach Villaverde, Island Doctors, St. Augustine, FL with Well Cell Global, Houston, TX.
Tori Tucker, Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA.
Michael Alexander, Department of Surgery, University of California Irvine, Orange, CA.
Scott A. Hepford, Department of Biomedical Engineering, University of California Irvine, Irvine, CA.
Jonathan RT Lakey*, Department of Surgery, University of California Irvine, Orange, CA.
& Department of Biomedical Engineering, University of California Irvine, Irvine, CA.
Roy H. Hinman II, Island Doctors, St. Augustine, FL with Well Cell Global, Houston, TX.
Case Series: Reversal of Diabetic Neuropathy Utilizing Physiologic Insulin Resensitization
Tori Tucker, Jennifer Hadley, Michael Alexander, Jonathan RT Lakey and Brian Loveridge
Dynamic Diabetes Solutions: Physiologic Insulin Resensitization
Brian Loveridge
Tori Tucker
Melanie St. Laurent
Scott Hepford
Michael Alexander
Jonathan RT Lakey
Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology
Frank Greenway 1, Brian Loveridge 2, Richard M. Grimes 3, Tori R. Tucker 4, Michael Alexander 5, Scott A. Hepford 6, Justin Fontenot 7, Candi Nobles-James 8, Carol Wilson 9, Adam M. Starr 10, Mohammed Abdelsaid 11, Stanley T. Lewis 12 and Jonathan R. T. Lakey 5,
Other Sources
Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care
Lia Bally, Ph.D., Hood Thabit, Ph.D., Sara Hartnell, B.Sc., Eveline Andereggen, R.N., Yue Ruan, Ph.D., Malgorzata E. Wilinska, Ph.D., Mark L. Evans, M.D., Maria M. Wertli, Ph.D., Anthony P. Coll, M.B., B.S., Christoph Stettler, M.D., and Roman Hovorka, Ph.D.
Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes
Leslie S. Satin, Ph.D,* Peter C. Butler, M.D, Joon Ha, Ph. D, and Arthur S. Sherman, Ph.D
Closing in on the Mechanisms of Pulsatile Insulin Secretion
Richard Bertram, Leslie S. Satin, and Arthur S. Sherman